İstanbul escort bayan sivas escort samsun escort bayan sakarya escort Muğla escort Mersin escort Escort malatya Escort konya Kocaeli Escort Kayseri Escort izmir escort bayan hatay bayan escort antep Escort bayan eskişehir escort bayan erzurum escort bayan elazığ escort diyarbakır escort escort bayan Çanakkale Bursa Escort bayan Balıkesir escort aydın Escort Antalya Escort ankara bayan escort Adana Escort bayan

63.4 F
San Diego
Tuesday, May 21, 2024
-Advertisement-

Pfenex Inc. Reports Q3 Results

Pfenex Inc., a clinical-stage biotechnology company developing biosimilar therapeutics, reported third quarter financial earnings.

The San Diego firm reported a net loss of $7.6 million, up from a net loss of $2.5 million in the same period last year. Revenue was $2.1 million, down from $2.8 million in Q3 of 2014. Research and development expenses were up to $5.7 million in the third quarter, compared with only $1.3 million in the same period last year.

Cash and cash equivalents as of September 30, 2015 was $115.9 million.

The earnings were stronger than expected by analysts, and its stock was up immediately following the announcement. It’s trading on the New York Stock Exchange under the stock symbol PFNX.

-Advertisement-

Featured Articles

Hair Today, Hair Tomorrow

Oberon Eyes Europe for Renewable DME

Leaders of Influence in Law 2024

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-